Virogenomics: A novel approach to antiviral drug discovery

Klaus Früh, Kenneth Simmen, B. G.Mattias Luukkonen, Yolanda C. Bell, Peter Ghazal

Research output: Contribution to journalReview article

28 Scopus citations

Abstract

Target discovery in virology has been limited to the few open-reading frames encoded by viral genomes. However, several recent examples show that inhibiting host-cell proteins can prevent viral infection. The human genome sequence should, therefore, contain many more genes that are essential for viral propagation than viral genomes. A systematic approach to find these potential cellular antiviral targets is global host gene expression analysis using DNA microarrays. Several recent studies reveal both unique and common strategies by which viruses change the gene expression profile of the host cell. Moreover, work in progress shows that some of the host pathways discovered by expression profiling are important for viral replication. Thus, human genomics tools have the potential to deliver novel antiviral drugs.

Original languageEnglish (US)
Pages (from-to)621-627
Number of pages7
JournalDrug Discovery Today
Volume6
Issue number12
DOIs
StatePublished - Jun 1 2001

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Virogenomics: A novel approach to antiviral drug discovery'. Together they form a unique fingerprint.

  • Cite this

    Früh, K., Simmen, K., Luukkonen, B. G. M., Bell, Y. C., & Ghazal, P. (2001). Virogenomics: A novel approach to antiviral drug discovery. Drug Discovery Today, 6(12), 621-627. https://doi.org/10.1016/S1359-6446(01)01808-6